Fellow new investor Adage Capital Management also backed the round alongside existing investors 3×5 Special Opportunity Fund, Morgenthaler Ventures, Integral Capital Partners, QuestMark Partners and Cross Creek Capital.
Gilde general partner Geoff Pardo said, “We are excited by the Vapotherm opportunity and delighted to join the investor group.
“Vapotherm’s proprietary technology has proven to generate superior patient outcomes and lower the cost of care for providers.
“We look forward to the company growing and improving healthcare for patients world wide.”
The New Hampshire, US-based company develops non-invasive technologies for respiratory support of patients with chronic or acute breathing disorders.
Copyright © 2014 AltAssets